Dr. Helen Baker's headshot

Dr. Helen Baker

Director, Formulation Design

Subject Expert
About

Dr. Helen Baker has over 15 years of formulation and product development experience within the pharmaceutical, biotech, and agronomical industries. Helen has expertise in the formulation of poorly soluble and bioavailable, amorphous, and physically and chemically labile compounds.

Prior to joining Quotient Sciences, Helen managed numerous formulation development, plant scale-up, and R&D endeavors across multiple industries. She holds a Ph.D. in chemistry and chemical engineering from the University of Manchester.

How does Translational Pharmaceutics® disrupt drug development?
Learn how we conduct Translational Pharmaceutics® from our U.S. facilities and the difference that it makes in drug development: Q&A with Drs. Vanessa Zann and Helen Baker

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, Artificial Intelligence Andy Lewis on AI‑Enabled Formulation Design and Faster Speed to Clinic By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Early Drug Development, Artificial Intelligence AI's Role in Fast-tracking Early Drug Development; Our ground breaking alliance with Intrepid Labs By: Andy Lewis
Read More
News & Announcements, Articles & Publications, Artificial Intelligence Building Trust in AI‑Enabled Formulation: Insights from Quotient Sciences and Intrepid Labs By: Andy Lewis
Read More
Let's Talk
Humanity can't wait, so neither can we. Discuss your drug program today.